vs

Side-by-side financial comparison of AMTECH SYSTEMS INC (ASYS) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

AMTECH SYSTEMS INC is the larger business by last-quarter revenue ($19.0M vs $14.7M, roughly 1.3× IRIDEX CORP). On growth, AMTECH SYSTEMS INC posted the faster year-over-year revenue change (-22.2% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -13.6%).

Amtech Systems Inc is a global manufacturer of advanced thermal processing and automation equipment primarily serving the semiconductor, solar photovoltaic, and LED production sectors. Its product portfolio includes soldering, diffusion, and deposition systems, with key markets spanning North America, East Asia, and Western Europe, catering to leading electronic component and clean energy manufacturing clients.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

ASYS vs IRIX — Head-to-Head

Bigger by revenue
ASYS
ASYS
1.3× larger
ASYS
$19.0M
$14.7M
IRIX
Growing faster (revenue YoY)
ASYS
ASYS
+47.6% gap
ASYS
-22.2%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-13.6%
ASYS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ASYS
ASYS
IRIX
IRIX
Revenue
$19.0M
$14.7M
Net Profit
$108.0K
Gross Margin
44.8%
37.2%
Operating Margin
4.1%
Net Margin
0.6%
Revenue YoY
-22.2%
-69.7%
Net Profit YoY
-65.4%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASYS
ASYS
IRIX
IRIX
Q4 25
$19.0M
$14.7M
Q3 25
$19.8M
$12.5M
Q2 25
$19.6M
$13.6M
Q1 25
$15.6M
$11.9M
Q4 24
$24.4M
$12.7M
Q3 24
$24.1M
$11.6M
Q2 24
$26.7M
$12.6M
Q1 24
$25.4M
$11.8M
Net Profit
ASYS
ASYS
IRIX
IRIX
Q4 25
$108.0K
Q3 25
$1.1M
$-1.6M
Q2 25
$106.0K
$-994.0K
Q1 25
$-31.8M
$-1.7M
Q4 24
$312.0K
$-834.0K
Q3 24
$-536.0K
$-1.9M
Q2 24
$438.0K
$-2.7M
Q1 24
$970.0K
$-3.5M
Gross Margin
ASYS
ASYS
IRIX
IRIX
Q4 25
44.8%
37.2%
Q3 25
44.4%
32.1%
Q2 25
46.7%
34.5%
Q1 25
-2.1%
42.5%
Q4 24
38.4%
44.0%
Q3 24
40.7%
37.3%
Q2 24
36.5%
40.7%
Q1 24
33.2%
37.9%
Operating Margin
ASYS
ASYS
IRIX
IRIX
Q4 25
4.1%
Q3 25
9.3%
-11.3%
Q2 25
4.7%
-6.9%
Q1 25
-202.7%
-1.7%
Q4 24
1.4%
-3.9%
Q3 24
0.1%
-16.1%
Q2 24
3.1%
-20.9%
Q1 24
5.4%
-28.0%
Net Margin
ASYS
ASYS
IRIX
IRIX
Q4 25
0.6%
Q3 25
5.4%
-12.6%
Q2 25
0.5%
-7.3%
Q1 25
-204.2%
-14.2%
Q4 24
1.3%
-6.6%
Q3 24
-2.2%
-16.7%
Q2 24
1.6%
-21.2%
Q1 24
3.8%
-29.5%
EPS (diluted)
ASYS
ASYS
IRIX
IRIX
Q4 25
$0.01
Q3 25
$0.08
$-0.09
Q2 25
$0.01
$-0.06
Q1 25
$-2.23
$-0.10
Q4 24
$0.02
$-0.05
Q3 24
$-0.04
$-0.12
Q2 24
$0.03
$-0.16
Q1 24
$0.07
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASYS
ASYS
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$22.1M
$6.0M
Total DebtLower is stronger
$162.0K
Stockholders' EquityBook value
$54.1M
Total Assets
$94.1M
$29.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASYS
ASYS
IRIX
IRIX
Q4 25
$22.1M
$6.0M
Q3 25
$17.9M
$5.6M
Q2 25
$15.6M
$6.8M
Q1 25
$13.4M
$7.2M
Q4 24
$13.2M
$2.4M
Q3 24
$11.1M
$3.9M
Q2 24
$13.2M
$4.1M
Q1 24
$13.0M
$5.4M
Total Debt
ASYS
ASYS
IRIX
IRIX
Q4 25
$162.0K
Q3 25
$168.0K
Q2 25
$127.0K
Q1 25
$135.0K
Q4 24
$161.0K
$1.0M
Q3 24
$189.0K
$1.4M
Q2 24
$177.0K
Q1 24
$65.0K
Stockholders' Equity
ASYS
ASYS
IRIX
IRIX
Q4 25
$54.1M
Q3 25
$53.4M
$4.7M
Q2 25
$51.7M
$6.1M
Q1 25
$51.0M
$852.0K
Q4 24
$82.4M
$2.1M
Q3 24
$82.4M
$2.6M
Q2 24
$81.7M
$4.2M
Q1 24
$80.9M
$6.5M
Total Assets
ASYS
ASYS
IRIX
IRIX
Q4 25
$94.1M
$29.2M
Q3 25
$92.9M
$28.4M
Q2 25
$89.5M
$31.6M
Q1 25
$83.4M
$34.2M
Q4 24
$117.8M
$29.1M
Q3 24
$119.3M
$30.2M
Q2 24
$127.1M
$31.2M
Q1 24
$116.5M
$34.1M
Debt / Equity
ASYS
ASYS
IRIX
IRIX
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
0.48×
Q3 24
0.00×
0.53×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASYS
ASYS
IRIX
IRIX
Operating Cash FlowLast quarter
$4.1M
Free Cash FlowOCF − Capex
$3.8M
FCF MarginFCF / Revenue
20.2%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
37.99×
TTM Free Cash FlowTrailing 4 quarters
$8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASYS
ASYS
IRIX
IRIX
Q4 25
$4.1M
Q3 25
$2.3M
$-1.2M
Q2 25
$2.5M
$-397.0K
Q1 25
$210.0K
$-1.1M
Q4 24
$2.9M
$-1.2M
Q3 24
$879.0K
$-3.1M
Q2 24
$3.7M
$-1.3M
Q1 24
$336.0K
$-1.6M
Free Cash Flow
ASYS
ASYS
IRIX
IRIX
Q4 25
$3.8M
Q3 25
$2.0M
$-1.2M
Q2 25
$2.0M
$-410.0K
Q1 25
$201.0K
$-1.2M
Q4 24
$2.7M
$-1.2M
Q3 24
$447.0K
$-3.1M
Q2 24
$322.0K
Q1 24
$-884.0K
$-1.7M
FCF Margin
ASYS
ASYS
IRIX
IRIX
Q4 25
20.2%
Q3 25
10.2%
-9.4%
Q2 25
10.1%
-3.0%
Q1 25
1.3%
-9.8%
Q4 24
11.2%
-9.8%
Q3 24
1.9%
-26.5%
Q2 24
1.2%
Q1 24
-3.5%
-14.0%
Capex Intensity
ASYS
ASYS
IRIX
IRIX
Q4 25
1.5%
Q3 25
1.2%
0.1%
Q2 25
2.8%
0.1%
Q1 25
0.1%
0.1%
Q4 24
0.6%
0.1%
Q3 24
1.8%
0.0%
Q2 24
12.5%
0.0%
Q1 24
4.8%
0.0%
Cash Conversion
ASYS
ASYS
IRIX
IRIX
Q4 25
37.99×
Q3 25
2.12×
Q2 25
23.89×
Q1 25
Q4 24
9.19×
Q3 24
Q2 24
8.35×
Q1 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASYS
ASYS

Thermal Processing Solutions$14.0M74%
Semiconductor Fabrication Solutions$5.0M26%

IRIX
IRIX

Segment breakdown not available.

Related Comparisons